ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders

ClinicalTrials.gov ID: NCT05262517

Public ClinicalTrials.gov record NCT05262517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 1:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Temporomandibular Disorders (TMD)

Study identification

NCT ID
NCT05262517
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
126 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Rimegepant Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 4, 2022
Primary completion
May 17, 2023
Completion
May 17, 2023
Last update posted
May 15, 2024

2022 – 2023

United States locations

U.S. sites
32
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Bruce Nelson, DDS Phoenix Arizona 85020
Arizona Research Center Phoenix Arizona 85053
The Medici Medical Research, LLC Hollywood Florida 33021
The Medici Medical Research Hollywood Florida 33021
SouthCoast Research Center, Inc Miami Florida 33136
SouthCoast Research Center Miami Florida 33136
Oceane7 Medical & Research Center, Inc. Miami Florida 33144
Florida Craniofacial Institute Tampa Florida 33607
Forcare Clinical Research Tampa Florida 33613
Campus Health, Indiana University-Purdue University Indianapolis Indianapolis Indiana 46202
IDS-IU Simon Cancer Center (IUSCC) Indianapolis Indiana 46202
Indiana University School of Dentistry Indianapolis Indiana 46202
University of Kentucky, College of Dentistry Lexington Kentucky 40536
TMD, Orofacial Pain and Dental Sleep Medicine Clinic, School of Dentistry, University of Minnesota Minneapolis Minnesota 55455
University of Minnesota Minneapolis Minnesota 55455
Clinvest Research, LLC Springfield Missouri 65807
Clinvest Research Springfield Missouri 65810
North Suffolk Neurology Commack New York 11725
University of Rochester Rochester New York 14618
Duke University Raleigh North Carolina 27617
META Medical Research Institute,LLC. Dayton Ohio 45432
Meta Medical Research Dayton Ohio 45432
Kulkarni Orthodonties Springboro Ohio 45066
Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104
University of Pittsburgh Pittsburgh Pennsylvania 15201
Red Star Research, LLC Lake Jackson Texas 77566
Red Star Research Lake Jackson Texas 77566
FMC Science Lampasas Texas 76550
JBR Clinical Research Salt Lake City Utah 84107
JBR Salt Lake City Utah 84107
Northwest Clinical Research Center Bellevue Washington 98007
Snoring and Sleep Apnea Center (DC/TMD Exam - Dr. Christian) Seattle Washington 98121

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05262517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 15, 2024 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05262517 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →